Topics

Biosimilar Information Wars: Draft Guidance Seeks To Clamp Down On Efforts To Hinder Uptake In The US

13:05 EST 3 Feb 2020 | SCRIP

The guidance states that promotion creating an impression that differences are clinically meaningful when the US FDA has said they...

      

Related Stories

 

Original Article: Biosimilar Information Wars: Draft Guidance Seeks To Clamp Down On Efforts To Hinder Uptake In The US

NEXT ARTICLE

More From BioPortfolio on "Biosimilar Information Wars: Draft Guidance Seeks To Clamp Down On Efforts To Hinder Uptake In The US"

Quick Search